These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8265420)

  • 21. A profile of neuropsychiatric problems and their relationship to quality of life for Parkinson's disease patients without dementia.
    McKinlay A; Grace RC; Dalrymple-Alford JC; Anderson T; Fink J; Roger D
    Parkinsonism Relat Disord; 2008; 14(1):37-42. PubMed ID: 17627863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroimaging of nonmotor features of Parkinson's disease.
    Deblieck C; Wu AD
    Rev Neurol Dis; 2008; 5(3):125-33. PubMed ID: 18838952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medicine-taking behavior: implications of suboptimal compliance in Parkinson's disease.
    Grosset KA; Reid JL; Grosset DG
    Mov Disord; 2005 Nov; 20(11):1397-404. PubMed ID: 16092116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health-related quality of life in Parkinson's disease after pallidotomy and deep brain stimulation.
    Straits-Tröster K; Fields JA; Wilkinson SB; Pahwa R; Lyons KE; Koller WC; Tröster AI
    Brain Cogn; 2000 Apr; 42(3):399-416. PubMed ID: 10753487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility and impact of a function focused care intervention for Parkinson's disease in the community.
    Pretzer-Aboff I; Galik E; Resnick B
    Nurs Res; 2011; 60(4):276-83. PubMed ID: 21691241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study.
    Okun MS; Fernandez HH; Rodriguez RL; Romrell J; Suelter M; Munson S; Louis ED; Mulligan T; Foster PS; Shenal BV; Armaghani SJ; Jacobson C; Wu S; Crucian G
    Arch Neurol; 2006 May; 63(5):729-35. PubMed ID: 16682542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Quality of life for patients with intractable diseases. Subjective satisfaction of patients with Parkinson's disease].
    Fujii C; Aoshima T; Sato S; Morita T; Ohkoshi N; Nakamura T; Oda S
    Kango Kenkyu; 1997; 30(4):11-21. PubMed ID: 9362843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Globus pallidus stimulation improves both motor and nonmotor aspects of quality of life in advanced Parkinson's disease.
    Rodrigues JP; Walters SE; Watson P; Stell R; Mastaglia FL
    Mov Disord; 2007 Oct; 22(13):1866-70. PubMed ID: 17659634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Common nursing problems in Parkinson's disease.
    Suddes M
    Elder Care; 1999 Jun; 11(4):31-4. PubMed ID: 10614274
    [No Abstract]   [Full Text] [Related]  

  • 30. Six weeks of intensive treadmill training improves gait and quality of life in patients with Parkinson's disease: a pilot study.
    Herman T; Giladi N; Gruendlinger L; Hausdorff JM
    Arch Phys Med Rehabil; 2007 Sep; 88(9):1154-8. PubMed ID: 17826461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deep brain stimulation: a new treatment for Parkinson's disease.
    Damian M; Davis TL; Konrad PE; Roberts AG; Pfister AA; Charles PD
    Tenn Med; 2003 Jan; 96(1):33-5. PubMed ID: 12602053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sweating dysfunction in Parkinson's disease.
    Swinn L; Schrag A; Viswanathan R; Bloem BR; Lees A; Quinn N
    Mov Disord; 2003 Dec; 18(12):1459-63. PubMed ID: 14673882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neuropsychiatric problems in patients with Parkinson's disease].
    Zhou MZ; Liu ZG; Gan J; Chen W; Lu LX; Wu JY
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(21):1442-5. PubMed ID: 18953846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cost and quality aspects in the treatment of Parkinson's disease].
    Müller T; Dodel R; Fritze J
    Z Arztl Fortbild Qualitatssich; 2006; 100(4):291-5. PubMed ID: 16878798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parkinson's disease--Part 3: Neuropsychiatric symptoms.
    Weintraub D; Comella CL; Horn S
    Am J Manag Care; 2008 Mar; 14(2 Suppl):S59-69. PubMed ID: 18402509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
    Parkinson Study Group CALM Cohort Investigators
    Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome measures for clinical trials in Parkinson's disease: achievements and shortcomings.
    Marras C; Lang AE
    Expert Rev Neurother; 2004 Nov; 4(6):985-93. PubMed ID: 15853525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Non-motor disorders in Parkinson's disease].
    Merello M
    Rev Neurol; 2008 Sep 1-15; 47(5):261-70. PubMed ID: 18780273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Qigong exercise for the symptoms of Parkinson's disease: a randomized, controlled pilot study.
    Schmitz-Hübsch T; Pyfer D; Kielwein K; Fimmers R; Klockgether T; Wüllner U
    Mov Disord; 2006 Apr; 21(4):543-8. PubMed ID: 16229022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse events from the treatment of Parkinson's disease.
    Chou KL
    Neurol Clin; 2008 Aug; 26(3 Suppl):S65-83, vi. PubMed ID: 18774443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.